Global Immune Globulins Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Immune Globulins market size was valued at US$ 14890 million in 2023. With growing demand in downstream market, the Immune Globulins is forecast to a readjusted size of US$ 25160 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Immune Globulins market. Immune Globulins are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune Globulins. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune Globulins market.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Key Features:
The report on Immune Globulins market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune Globulins market. It may include historical data, market segmentation by Type (e.g., IVIg Liquid, IVIg Powder), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune Globulins market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune Globulins market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune Globulins industry. This include advancements in Immune Globulins technology, Immune Globulins new entrants, Immune Globulins new investment, and other innovations that are shaping the future of Immune Globulins.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune Globulins market. It includes factors influencing customer ' purchasing decisions, preferences for Immune Globulins product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune Globulins market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune Globulins market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune Globulins market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune Globulins industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune Globulins market.
Market Segmentation:
Immune Globulins market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Immune Globulins market?
What factors are driving Immune Globulins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Globulins market opportunities vary by end market size?
How does Immune Globulins break out type, application?
According to our LPI (LP Information) latest study, the global Immune Globulins market size was valued at US$ 14890 million in 2023. With growing demand in downstream market, the Immune Globulins is forecast to a readjusted size of US$ 25160 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Immune Globulins market. Immune Globulins are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune Globulins. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune Globulins market.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Key Features:
The report on Immune Globulins market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune Globulins market. It may include historical data, market segmentation by Type (e.g., IVIg Liquid, IVIg Powder), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune Globulins market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune Globulins market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune Globulins industry. This include advancements in Immune Globulins technology, Immune Globulins new entrants, Immune Globulins new investment, and other innovations that are shaping the future of Immune Globulins.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune Globulins market. It includes factors influencing customer ' purchasing decisions, preferences for Immune Globulins product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune Globulins market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune Globulins market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune Globulins market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune Globulins industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune Globulins market.
Market Segmentation:
Immune Globulins market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- IVIg Liquid
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
What is the 10-year outlook for the global Immune Globulins market?
What factors are driving Immune Globulins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Globulins market opportunities vary by end market size?
How does Immune Globulins break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Globulins Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Immune Globulins by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Immune Globulins by Country/Region, 2019, 2023 & 2030
2.2 Immune Globulins Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Immune Globulins Sales by Type
2.3.1 Global Immune Globulins Sales Market Share by Type (2019-2024)
2.3.2 Global Immune Globulins Revenue and Market Share by Type (2019-2024)
2.3.3 Global Immune Globulins Sale Price by Type (2019-2024)
2.4 Immune Globulins Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Immune Globulins Sales by Application
2.5.1 Global Immune Globulins Sale Market Share by Application (2019-2024)
2.5.2 Global Immune Globulins Revenue and Market Share by Application (2019-2024)
2.5.3 Global Immune Globulins Sale Price by Application (2019-2024)
3 GLOBAL IMMUNE GLOBULINS BY COMPANY
3.1 Global Immune Globulins Breakdown Data by Company
3.1.1 Global Immune Globulins Annual Sales by Company (2019-2024)
3.1.2 Global Immune Globulins Sales Market Share by Company (2019-2024)
3.2 Global Immune Globulins Annual Revenue by Company (2019-2024)
3.2.1 Global Immune Globulins Revenue by Company (2019-2024)
3.2.2 Global Immune Globulins Revenue Market Share by Company (2019-2024)
3.3 Global Immune Globulins Sale Price by Company
3.4 Key Manufacturers Immune Globulins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Globulins Product Location Distribution
3.4.2 Players Immune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNE GLOBULINS BY GEOGRAPHIC REGION
4.1 World Historic Immune Globulins Market Size by Geographic Region (2019-2024)
4.1.1 Global Immune Globulins Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Immune Globulins Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Immune Globulins Market Size by Country/Region (2019-2024)
4.2.1 Global Immune Globulins Annual Sales by Country/Region (2019-2024)
4.2.2 Global Immune Globulins Annual Revenue by Country/Region (2019-2024)
4.3 Americas Immune Globulins Sales Growth
4.4 APAC Immune Globulins Sales Growth
4.5 Europe Immune Globulins Sales Growth
4.6 Middle East & Africa Immune Globulins Sales Growth
5 AMERICAS
5.1 Americas Immune Globulins Sales by Country
5.1.1 Americas Immune Globulins Sales by Country (2019-2024)
5.1.2 Americas Immune Globulins Revenue by Country (2019-2024)
5.2 Americas Immune Globulins Sales by Type
5.3 Americas Immune Globulins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Globulins Sales by Region
6.1.1 APAC Immune Globulins Sales by Region (2019-2024)
6.1.2 APAC Immune Globulins Revenue by Region (2019-2024)
6.2 APAC Immune Globulins Sales by Type
6.3 APAC Immune Globulins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Globulins by Country
7.1.1 Europe Immune Globulins Sales by Country (2019-2024)
7.1.2 Europe Immune Globulins Revenue by Country (2019-2024)
7.2 Europe Immune Globulins Sales by Type
7.3 Europe Immune Globulins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Globulins by Country
8.1.1 Middle East & Africa Immune Globulins Sales by Country (2019-2024)
8.1.2 Middle East & Africa Immune Globulins Revenue by Country (2019-2024)
8.2 Middle East & Africa Immune Globulins Sales by Type
8.3 Middle East & Africa Immune Globulins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Globulins
10.3 Manufacturing Process Analysis of Immune Globulins
10.4 Industry Chain Structure of Immune Globulins
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Globulins Distributors
11.3 Immune Globulins Customer
12 WORLD FORECAST REVIEW FOR IMMUNE GLOBULINS BY GEOGRAPHIC REGION
12.1 Global Immune Globulins Market Size Forecast by Region
12.1.1 Global Immune Globulins Forecast by Region (2025-2030)
12.1.2 Global Immune Globulins Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Globulins Forecast by Type
12.7 Global Immune Globulins Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Immune Globulins Product Portfolios and Specifications
13.1.3 Takeda Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Immune Globulins Product Portfolios and Specifications
13.2.3 Grifols Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Immune Globulins Product Portfolios and Specifications
13.3.3 CSL Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Immune Globulins Product Portfolios and Specifications
13.4.3 Octapharma Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Immune Globulins Product Portfolios and Specifications
13.5.3 Biotest Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Immune Globulins Product Portfolios and Specifications
13.6.3 Kedrion Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Immune Globulins Product Portfolios and Specifications
13.7.3 Hualan Bio Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Immune Globulins Product Portfolios and Specifications
13.8.3 CNBG Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Immune Globulins Product Portfolios and Specifications
13.9.3 Shanghai RAAS Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Immune Globulins Product Portfolios and Specifications
13.10.3 CBPO Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Immune Globulins Product Portfolios and Specifications
13.11.3 LFB Group Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Immune Globulins Product Portfolios and Specifications
13.12.3 BPL Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
13.13.1 Sichuan Yuanda Shuyang Company Information
13.13.2 Sichuan Yuanda Shuyang Immune Globulins Product Portfolios and Specifications
13.13.3 Sichuan Yuanda Shuyang Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Sichuan Yuanda Shuyang Main Business Overview
13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Globulins Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Immune Globulins by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Immune Globulins by Country/Region, 2019, 2023 & 2030
2.2 Immune Globulins Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Immune Globulins Sales by Type
2.3.1 Global Immune Globulins Sales Market Share by Type (2019-2024)
2.3.2 Global Immune Globulins Revenue and Market Share by Type (2019-2024)
2.3.3 Global Immune Globulins Sale Price by Type (2019-2024)
2.4 Immune Globulins Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Immune Globulins Sales by Application
2.5.1 Global Immune Globulins Sale Market Share by Application (2019-2024)
2.5.2 Global Immune Globulins Revenue and Market Share by Application (2019-2024)
2.5.3 Global Immune Globulins Sale Price by Application (2019-2024)
3 GLOBAL IMMUNE GLOBULINS BY COMPANY
3.1 Global Immune Globulins Breakdown Data by Company
3.1.1 Global Immune Globulins Annual Sales by Company (2019-2024)
3.1.2 Global Immune Globulins Sales Market Share by Company (2019-2024)
3.2 Global Immune Globulins Annual Revenue by Company (2019-2024)
3.2.1 Global Immune Globulins Revenue by Company (2019-2024)
3.2.2 Global Immune Globulins Revenue Market Share by Company (2019-2024)
3.3 Global Immune Globulins Sale Price by Company
3.4 Key Manufacturers Immune Globulins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Globulins Product Location Distribution
3.4.2 Players Immune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNE GLOBULINS BY GEOGRAPHIC REGION
4.1 World Historic Immune Globulins Market Size by Geographic Region (2019-2024)
4.1.1 Global Immune Globulins Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Immune Globulins Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Immune Globulins Market Size by Country/Region (2019-2024)
4.2.1 Global Immune Globulins Annual Sales by Country/Region (2019-2024)
4.2.2 Global Immune Globulins Annual Revenue by Country/Region (2019-2024)
4.3 Americas Immune Globulins Sales Growth
4.4 APAC Immune Globulins Sales Growth
4.5 Europe Immune Globulins Sales Growth
4.6 Middle East & Africa Immune Globulins Sales Growth
5 AMERICAS
5.1 Americas Immune Globulins Sales by Country
5.1.1 Americas Immune Globulins Sales by Country (2019-2024)
5.1.2 Americas Immune Globulins Revenue by Country (2019-2024)
5.2 Americas Immune Globulins Sales by Type
5.3 Americas Immune Globulins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Globulins Sales by Region
6.1.1 APAC Immune Globulins Sales by Region (2019-2024)
6.1.2 APAC Immune Globulins Revenue by Region (2019-2024)
6.2 APAC Immune Globulins Sales by Type
6.3 APAC Immune Globulins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Globulins by Country
7.1.1 Europe Immune Globulins Sales by Country (2019-2024)
7.1.2 Europe Immune Globulins Revenue by Country (2019-2024)
7.2 Europe Immune Globulins Sales by Type
7.3 Europe Immune Globulins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Globulins by Country
8.1.1 Middle East & Africa Immune Globulins Sales by Country (2019-2024)
8.1.2 Middle East & Africa Immune Globulins Revenue by Country (2019-2024)
8.2 Middle East & Africa Immune Globulins Sales by Type
8.3 Middle East & Africa Immune Globulins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Globulins
10.3 Manufacturing Process Analysis of Immune Globulins
10.4 Industry Chain Structure of Immune Globulins
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Globulins Distributors
11.3 Immune Globulins Customer
12 WORLD FORECAST REVIEW FOR IMMUNE GLOBULINS BY GEOGRAPHIC REGION
12.1 Global Immune Globulins Market Size Forecast by Region
12.1.1 Global Immune Globulins Forecast by Region (2025-2030)
12.1.2 Global Immune Globulins Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Globulins Forecast by Type
12.7 Global Immune Globulins Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Immune Globulins Product Portfolios and Specifications
13.1.3 Takeda Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Immune Globulins Product Portfolios and Specifications
13.2.3 Grifols Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Immune Globulins Product Portfolios and Specifications
13.3.3 CSL Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Immune Globulins Product Portfolios and Specifications
13.4.3 Octapharma Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Immune Globulins Product Portfolios and Specifications
13.5.3 Biotest Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Immune Globulins Product Portfolios and Specifications
13.6.3 Kedrion Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Immune Globulins Product Portfolios and Specifications
13.7.3 Hualan Bio Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Immune Globulins Product Portfolios and Specifications
13.8.3 CNBG Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Immune Globulins Product Portfolios and Specifications
13.9.3 Shanghai RAAS Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Immune Globulins Product Portfolios and Specifications
13.10.3 CBPO Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Immune Globulins Product Portfolios and Specifications
13.11.3 LFB Group Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Immune Globulins Product Portfolios and Specifications
13.12.3 BPL Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
13.13.1 Sichuan Yuanda Shuyang Company Information
13.13.2 Sichuan Yuanda Shuyang Immune Globulins Product Portfolios and Specifications
13.13.3 Sichuan Yuanda Shuyang Immune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Sichuan Yuanda Shuyang Main Business Overview
13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immune Globulins Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Immune Globulins Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 6. Global Immune Globulins Sales Market Share by Type (2019-2024)
Table 7. Global Immune Globulins Revenue by Type (2019-2024) & ($ million)
Table 8. Global Immune Globulins Revenue Market Share by Type (2019-2024)
Table 9. Global Immune Globulins Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 11. Global Immune Globulins Sales Market Share by Application (2019-2024)
Table 12. Global Immune Globulins Revenue by Application (2019-2024)
Table 13. Global Immune Globulins Revenue Market Share by Application (2019-2024)
Table 14. Global Immune Globulins Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Immune Globulins Sales by Company (2019-2024) & (K Units)
Table 16. Global Immune Globulins Sales Market Share by Company (2019-2024)
Table 17. Global Immune Globulins Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Immune Globulins Revenue Market Share by Company (2019-2024)
Table 19. Global Immune Globulins Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Immune Globulins Producing Area Distribution and Sales Area
Table 21. Players Immune Globulins Products Offered
Table 22. Immune Globulins Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Immune Globulins Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Immune Globulins Sales Market Share Geographic Region (2019-2024)
Table 27. Global Immune Globulins Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Immune Globulins Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Immune Globulins Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Immune Globulins Sales Market Share by Country/Region (2019-2024)
Table 31. Global Immune Globulins Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Immune Globulins Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Immune Globulins Sales by Country (2019-2024) & (K Units)
Table 34. Americas Immune Globulins Sales Market Share by Country (2019-2024)
Table 35. Americas Immune Globulins Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Immune Globulins Revenue Market Share by Country (2019-2024)
Table 37. Americas Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 38. Americas Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 39. APAC Immune Globulins Sales by Region (2019-2024) & (K Units)
Table 40. APAC Immune Globulins Sales Market Share by Region (2019-2024)
Table 41. APAC Immune Globulins Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Immune Globulins Revenue Market Share by Region (2019-2024)
Table 43. APAC Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 44. APAC Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 45. Europe Immune Globulins Sales by Country (2019-2024) & (K Units)
Table 46. Europe Immune Globulins Sales Market Share by Country (2019-2024)
Table 47. Europe Immune Globulins Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Immune Globulins Revenue Market Share by Country (2019-2024)
Table 49. Europe Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 50. Europe Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Immune Globulins Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Immune Globulins Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Immune Globulins Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Immune Globulins Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Immune Globulins
Table 58. Key Market Challenges & Risks of Immune Globulins
Table 59. Key Industry Trends of Immune Globulins
Table 60. Immune Globulins Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Immune Globulins Distributors List
Table 63. Immune Globulins Customer List
Table 64. Global Immune Globulins Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Immune Globulins Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Immune Globulins Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Immune Globulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Immune Globulins Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Immune Globulins Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Immune Globulins Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Immune Globulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Immune Globulins Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Immune Globulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Immune Globulins Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Immune Globulins Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Immune Globulins Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Immune Globulins Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Takeda Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Immune Globulins Product Portfolios and Specifications
Table 80. Takeda Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. Grifols Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Immune Globulins Product Portfolios and Specifications
Table 85. Grifols Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. CSL Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Immune Globulins Product Portfolios and Specifications
Table 90. CSL Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Octapharma Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Immune Globulins Product Portfolios and Specifications
Table 95. Octapharma Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Biotest Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 99. Biotest Immune Globulins Product Portfolios and Specifications
Table 100. Biotest Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Biotest Main Business
Table 102. Biotest Latest Developments
Table 103. Kedrion Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Immune Globulins Product Portfolios and Specifications
Table 105. Kedrion Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. Hualan Bio Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 109. Hualan Bio Immune Globulins Product Portfolios and Specifications
Table 110. Hualan Bio Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Hualan Bio Main Business
Table 112. Hualan Bio Latest Developments
Table 113. CNBG Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 114. CNBG Immune Globulins Product Portfolios and Specifications
Table 115. CNBG Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. CNBG Main Business
Table 117. CNBG Latest Developments
Table 118. Shanghai RAAS Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai RAAS Immune Globulins Product Portfolios and Specifications
Table 120. Shanghai RAAS Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Shanghai RAAS Main Business
Table 122. Shanghai RAAS Latest Developments
Table 123. CBPO Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 124. CBPO Immune Globulins Product Portfolios and Specifications
Table 125. CBPO Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. CBPO Main Business
Table 127. CBPO Latest Developments
Table 128. LFB Group Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 129. LFB Group Immune Globulins Product Portfolios and Specifications
Table 130. LFB Group Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. LFB Group Main Business
Table 132. LFB Group Latest Developments
Table 133. BPL Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 134. BPL Immune Globulins Product Portfolios and Specifications
Table 135. BPL Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. Sichuan Yuanda Shuyang Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 139. Sichuan Yuanda Shuyang Immune Globulins Product Portfolios and Specifications
Table 140. Sichuan Yuanda Shuyang Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Sichuan Yuanda Shuyang Main Business
Table 142. Sichuan Yuanda Shuyang Latest Developments
Table 1. Immune Globulins Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Immune Globulins Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 6. Global Immune Globulins Sales Market Share by Type (2019-2024)
Table 7. Global Immune Globulins Revenue by Type (2019-2024) & ($ million)
Table 8. Global Immune Globulins Revenue Market Share by Type (2019-2024)
Table 9. Global Immune Globulins Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 11. Global Immune Globulins Sales Market Share by Application (2019-2024)
Table 12. Global Immune Globulins Revenue by Application (2019-2024)
Table 13. Global Immune Globulins Revenue Market Share by Application (2019-2024)
Table 14. Global Immune Globulins Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Immune Globulins Sales by Company (2019-2024) & (K Units)
Table 16. Global Immune Globulins Sales Market Share by Company (2019-2024)
Table 17. Global Immune Globulins Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Immune Globulins Revenue Market Share by Company (2019-2024)
Table 19. Global Immune Globulins Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Immune Globulins Producing Area Distribution and Sales Area
Table 21. Players Immune Globulins Products Offered
Table 22. Immune Globulins Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Immune Globulins Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Immune Globulins Sales Market Share Geographic Region (2019-2024)
Table 27. Global Immune Globulins Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Immune Globulins Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Immune Globulins Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Immune Globulins Sales Market Share by Country/Region (2019-2024)
Table 31. Global Immune Globulins Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Immune Globulins Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Immune Globulins Sales by Country (2019-2024) & (K Units)
Table 34. Americas Immune Globulins Sales Market Share by Country (2019-2024)
Table 35. Americas Immune Globulins Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Immune Globulins Revenue Market Share by Country (2019-2024)
Table 37. Americas Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 38. Americas Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 39. APAC Immune Globulins Sales by Region (2019-2024) & (K Units)
Table 40. APAC Immune Globulins Sales Market Share by Region (2019-2024)
Table 41. APAC Immune Globulins Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Immune Globulins Revenue Market Share by Region (2019-2024)
Table 43. APAC Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 44. APAC Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 45. Europe Immune Globulins Sales by Country (2019-2024) & (K Units)
Table 46. Europe Immune Globulins Sales Market Share by Country (2019-2024)
Table 47. Europe Immune Globulins Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Immune Globulins Revenue Market Share by Country (2019-2024)
Table 49. Europe Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 50. Europe Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Immune Globulins Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Immune Globulins Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Immune Globulins Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Immune Globulins Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Immune Globulins Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Immune Globulins Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Immune Globulins
Table 58. Key Market Challenges & Risks of Immune Globulins
Table 59. Key Industry Trends of Immune Globulins
Table 60. Immune Globulins Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Immune Globulins Distributors List
Table 63. Immune Globulins Customer List
Table 64. Global Immune Globulins Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Immune Globulins Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Immune Globulins Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Immune Globulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Immune Globulins Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Immune Globulins Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Immune Globulins Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Immune Globulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Immune Globulins Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Immune Globulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Immune Globulins Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Immune Globulins Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Immune Globulins Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Immune Globulins Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Takeda Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Immune Globulins Product Portfolios and Specifications
Table 80. Takeda Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. Grifols Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Immune Globulins Product Portfolios and Specifications
Table 85. Grifols Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. CSL Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Immune Globulins Product Portfolios and Specifications
Table 90. CSL Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Octapharma Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Immune Globulins Product Portfolios and Specifications
Table 95. Octapharma Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Biotest Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 99. Biotest Immune Globulins Product Portfolios and Specifications
Table 100. Biotest Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Biotest Main Business
Table 102. Biotest Latest Developments
Table 103. Kedrion Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Immune Globulins Product Portfolios and Specifications
Table 105. Kedrion Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. Hualan Bio Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 109. Hualan Bio Immune Globulins Product Portfolios and Specifications
Table 110. Hualan Bio Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Hualan Bio Main Business
Table 112. Hualan Bio Latest Developments
Table 113. CNBG Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 114. CNBG Immune Globulins Product Portfolios and Specifications
Table 115. CNBG Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. CNBG Main Business
Table 117. CNBG Latest Developments
Table 118. Shanghai RAAS Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai RAAS Immune Globulins Product Portfolios and Specifications
Table 120. Shanghai RAAS Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Shanghai RAAS Main Business
Table 122. Shanghai RAAS Latest Developments
Table 123. CBPO Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 124. CBPO Immune Globulins Product Portfolios and Specifications
Table 125. CBPO Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. CBPO Main Business
Table 127. CBPO Latest Developments
Table 128. LFB Group Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 129. LFB Group Immune Globulins Product Portfolios and Specifications
Table 130. LFB Group Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. LFB Group Main Business
Table 132. LFB Group Latest Developments
Table 133. BPL Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 134. BPL Immune Globulins Product Portfolios and Specifications
Table 135. BPL Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. Sichuan Yuanda Shuyang Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 139. Sichuan Yuanda Shuyang Immune Globulins Product Portfolios and Specifications
Table 140. Sichuan Yuanda Shuyang Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Sichuan Yuanda Shuyang Main Business
Table 142. Sichuan Yuanda Shuyang Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immune Globulins
Figure 2. Immune Globulins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Globulins Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Immune Globulins Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Immune Globulins Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Immune Globulins Sales Market Share by Type in 2023
Figure 12. Global Immune Globulins Revenue Market Share by Type (2019-2024)
Figure 13. Immune Globulins Consumed in Immunodeficiency
Figure 14. Global Immune Globulins Market: Immunodeficiency (2019-2024) & (K Units)
Figure 15. Immune Globulins Consumed in Autoimmune Disease
Figure 16. Global Immune Globulins Market: Autoimmune Disease (2019-2024) & (K Units)
Figure 17. Immune Globulins Consumed in Acute Infection
Figure 18. Global Immune Globulins Market: Acute Infection (2019-2024) & (K Units)
Figure 19. Global Immune Globulins Sales Market Share by Application (2023)
Figure 20. Global Immune Globulins Revenue Market Share by Application in 2023
Figure 21. Immune Globulins Sales Market by Company in 2023 (K Units)
Figure 22. Global Immune Globulins Sales Market Share by Company in 2023
Figure 23. Immune Globulins Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Immune Globulins Revenue Market Share by Company in 2023
Figure 25. Global Immune Globulins Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Immune Globulins Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Immune Globulins Sales 2019-2024 (K Units)
Figure 28. Americas Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 29. APAC Immune Globulins Sales 2019-2024 (K Units)
Figure 30. APAC Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 31. Europe Immune Globulins Sales 2019-2024 (K Units)
Figure 32. Europe Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Immune Globulins Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 35. Americas Immune Globulins Sales Market Share by Country in 2023
Figure 36. Americas Immune Globulins Revenue Market Share by Country in 2023
Figure 37. Americas Immune Globulins Sales Market Share by Type (2019-2024)
Figure 38. Americas Immune Globulins Sales Market Share by Application (2019-2024)
Figure 39. United States Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Immune Globulins Sales Market Share by Region in 2023
Figure 44. APAC Immune Globulins Revenue Market Share by Regions in 2023
Figure 45. APAC Immune Globulins Sales Market Share by Type (2019-2024)
Figure 46. APAC Immune Globulins Sales Market Share by Application (2019-2024)
Figure 47. China Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Immune Globulins Sales Market Share by Country in 2023
Figure 55. Europe Immune Globulins Revenue Market Share by Country in 2023
Figure 56. Europe Immune Globulins Sales Market Share by Type (2019-2024)
Figure 57. Europe Immune Globulins Sales Market Share by Application (2019-2024)
Figure 58. Germany Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Immune Globulins Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Immune Globulins Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Immune Globulins Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Immune Globulins Sales Market Share by Application (2019-2024)
Figure 67. Egypt Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Immune Globulins in 2023
Figure 73. Manufacturing Process Analysis of Immune Globulins
Figure 74. Industry Chain Structure of Immune Globulins
Figure 75. Channels of Distribution
Figure 76. Global Immune Globulins Sales Market Forecast by Region (2025-2030)
Figure 77. Global Immune Globulins Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Immune Globulins Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Immune Globulins Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Immune Globulins Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Immune Globulins Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Immune Globulins
Figure 2. Immune Globulins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Globulins Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Immune Globulins Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Immune Globulins Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Immune Globulins Sales Market Share by Type in 2023
Figure 12. Global Immune Globulins Revenue Market Share by Type (2019-2024)
Figure 13. Immune Globulins Consumed in Immunodeficiency
Figure 14. Global Immune Globulins Market: Immunodeficiency (2019-2024) & (K Units)
Figure 15. Immune Globulins Consumed in Autoimmune Disease
Figure 16. Global Immune Globulins Market: Autoimmune Disease (2019-2024) & (K Units)
Figure 17. Immune Globulins Consumed in Acute Infection
Figure 18. Global Immune Globulins Market: Acute Infection (2019-2024) & (K Units)
Figure 19. Global Immune Globulins Sales Market Share by Application (2023)
Figure 20. Global Immune Globulins Revenue Market Share by Application in 2023
Figure 21. Immune Globulins Sales Market by Company in 2023 (K Units)
Figure 22. Global Immune Globulins Sales Market Share by Company in 2023
Figure 23. Immune Globulins Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Immune Globulins Revenue Market Share by Company in 2023
Figure 25. Global Immune Globulins Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Immune Globulins Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Immune Globulins Sales 2019-2024 (K Units)
Figure 28. Americas Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 29. APAC Immune Globulins Sales 2019-2024 (K Units)
Figure 30. APAC Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 31. Europe Immune Globulins Sales 2019-2024 (K Units)
Figure 32. Europe Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Immune Globulins Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Immune Globulins Revenue 2019-2024 ($ Millions)
Figure 35. Americas Immune Globulins Sales Market Share by Country in 2023
Figure 36. Americas Immune Globulins Revenue Market Share by Country in 2023
Figure 37. Americas Immune Globulins Sales Market Share by Type (2019-2024)
Figure 38. Americas Immune Globulins Sales Market Share by Application (2019-2024)
Figure 39. United States Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Immune Globulins Sales Market Share by Region in 2023
Figure 44. APAC Immune Globulins Revenue Market Share by Regions in 2023
Figure 45. APAC Immune Globulins Sales Market Share by Type (2019-2024)
Figure 46. APAC Immune Globulins Sales Market Share by Application (2019-2024)
Figure 47. China Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Immune Globulins Sales Market Share by Country in 2023
Figure 55. Europe Immune Globulins Revenue Market Share by Country in 2023
Figure 56. Europe Immune Globulins Sales Market Share by Type (2019-2024)
Figure 57. Europe Immune Globulins Sales Market Share by Application (2019-2024)
Figure 58. Germany Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Immune Globulins Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Immune Globulins Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Immune Globulins Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Immune Globulins Sales Market Share by Application (2019-2024)
Figure 67. Egypt Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Immune Globulins Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Immune Globulins in 2023
Figure 73. Manufacturing Process Analysis of Immune Globulins
Figure 74. Industry Chain Structure of Immune Globulins
Figure 75. Channels of Distribution
Figure 76. Global Immune Globulins Sales Market Forecast by Region (2025-2030)
Figure 77. Global Immune Globulins Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Immune Globulins Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Immune Globulins Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Immune Globulins Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Immune Globulins Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Vaccine Adjuvants Market Growth 2025-2031
US$ 3,660.00
March 2025
111 pages
Global Menthol Market Growth 2026-2032
US$ 3,660.00
January 2026
154 pages
Global Surgical Suction Tube Market Growth 2024-2030
US$ 3,660.00
December 2024
131 pages
